Pacira BioSciences Presents Real-World Evidence of EXPAREL and ioveraº for Knee Pain Management

Pacira BioSciences presented real-world studies from its Innovations in Genicular Outcomes Registry (IGOR) at the American Academy of Orthopedic Surgeons 2026 Annual Meeting. The studies highlighted the clinical effectiveness of EXPAREL for total knee arthroplasty and long-term pain management with iovera for patients with osteoarthritis of the knee. Data demonstrated improvements in pain, opioid use, function, and length of stay with EXPAREL after TKA and longer-term improvement in pain and function for up to 12 months with iovera.